TY - JOUR
T1 - Antioxidant potency of various fractions of okra pods extract to ameliorate liver structure and function in diabetic mice
AU - Husen, Saikhu Akhmad
AU - Winarni, Dwi
AU - Wahyuningsih, Sri Puji Astuti
AU - Ansori, Arif Nur Muhammad
AU - Hayaza, Suhailah
AU - Susilo, Raden Joko Kuncoroningrat
AU - Doong, Ruey An
AU - Darmanto, Win
N1 - Publisher Copyright:
© 2020, Agri. Bio. Publishers. All rights reserved.
PY - 2020/4
Y1 - 2020/4
N2 - The purpose of this study was to determine the potency of various fractions of okra pods extract (VOPE) as antidiabetic based on its effect on reducing fasting blood glucose, cholesterol level, SGOT and SGPT plasm level, also ameliorating damaged hepatocytes in diabetic mice. The antioxidant test was conducted by using 28 male BALB/C mice. The samples were divided into seven groups, namely, KN (normal control), KD (diabetic control), KA (acarbose control), EK (crude extract), NP (non-polar), SP (semi-polar), and EP (polar). VOPE and acarbose suspension administered orally for 14 days in STZ-induced diabetic mice. The diabetes was induced by intraperitoneal injection of multiple low-dose STZ (30 mg/kg body weight) daily for five consecutive days. Before and after STZ injection, fasting blood glucose and cholesterol level was measured. Treatment of VOPE was given for 14 days. On day 15th mice were sacrificed. Random blood glucose and cholesterol level were measured at 1st, 7th, and 14th day of VOPE treatment. At 15th day, SGOT and SGPT plasma levels were measured using Pentra C 200 Reader. The liver was collected and processed histologically. The results showed that VOPE administration was able to reduce fasting blood glucose, cholesterol level, SGOT and SGPT plasma level and ameliorate damaged hepatocytes in diabetic mice significantly.
AB - The purpose of this study was to determine the potency of various fractions of okra pods extract (VOPE) as antidiabetic based on its effect on reducing fasting blood glucose, cholesterol level, SGOT and SGPT plasm level, also ameliorating damaged hepatocytes in diabetic mice. The antioxidant test was conducted by using 28 male BALB/C mice. The samples were divided into seven groups, namely, KN (normal control), KD (diabetic control), KA (acarbose control), EK (crude extract), NP (non-polar), SP (semi-polar), and EP (polar). VOPE and acarbose suspension administered orally for 14 days in STZ-induced diabetic mice. The diabetes was induced by intraperitoneal injection of multiple low-dose STZ (30 mg/kg body weight) daily for five consecutive days. Before and after STZ injection, fasting blood glucose and cholesterol level was measured. Treatment of VOPE was given for 14 days. On day 15th mice were sacrificed. Random blood glucose and cholesterol level were measured at 1st, 7th, and 14th day of VOPE treatment. At 15th day, SGOT and SGPT plasma levels were measured using Pentra C 200 Reader. The liver was collected and processed histologically. The results showed that VOPE administration was able to reduce fasting blood glucose, cholesterol level, SGOT and SGPT plasma level and ameliorate damaged hepatocytes in diabetic mice significantly.
KW - Cholesterol level
KW - Diabetic mice
KW - Fasting blood glucose
KW - Hepatocyte
KW - SGOT
KW - SGPT
UR - http://www.scopus.com/inward/record.url?scp=85086153679&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85086153679
SN - 0970-0153
VL - 36
SP - 154
EP - 158
JO - Annals of Biology
JF - Annals of Biology
IS - 2
ER -